Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Name_less_
    Member
    • Oct 2014
    • 12

    Chip-seq data questions

    Hello
    I need work with Chip-seq of 3 conditions (WT, C and V). It’s single-end.
    When I saw the data, questions born:

    1. Each sample has duplicate, but each duplicate has 4 fastq files corresponding to “lanes” of the sequencing. That’s mean that the 4 files correspond to one sample? If so... Would I join the 4 fastq files for work with them as one sample?

    2. Other sequencing data are present, with names WTIN, CIN and VIN (each one with 4 fastq files). The text file that I received says: “Each experiment was performed in duplicate, the sequencing was through NextSeq with a 76ntSR reading format, single entry income for each sample marked as WTIN, CIN and VIN.” Someone known whats that mean?

    Thanks to everyone!
  • nucacidhunter
    Jafar Jabbari
    • Jan 2013
    • 1250

    #2
    1- Libraries has been sequenced on a NextSeq flow cell that has 4 lanes so the data from lanes for each library needs to be merged into one file for each sample replicates for analysis.

    2- You need to clarify this with data supplier. The terms "WTIN, CIN and VIN" simply could refer to your sample names for WT, C and V, respectively. I would normally name them as WTIN_1, WTIN_2 ... to identify each replicate.

    Comment

    • Name_less_
      Member
      • Oct 2014
      • 12

      #3
      Originally posted by nucacidhunter View Post
      1- Libraries has been sequenced on a NextSeq flow cell that has 4 lanes so the data from lanes for each library needs to be merged into one file for each sample replicates for analysis.

      2- You need to clarify this with data supplier. The terms "WTIN, CIN and VIN" simply could refer to your sample names for WT, C and V, respectively. I would normally name them as WTIN_1, WTIN_2 ... to identify each replicate.
      Thank you! So I will merge the fastq files.
      Referent to point 2:
      I have 9 folders, 2 for each replicate (WT1, WT2, C1, C2, V1, V2) and other three (WTIN, CIN, VIN). I talked with my friend and he told me that, possibly, the WTIN, CIN and VIN correspond to control of sequencing. So, I will take some reads sequence and will make Blast.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      18 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      32 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-09-2026, 10:04 AM
      0 responses
      43 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-08-2026, 10:08 AM
      0 responses
      29 views
      0 reactions
      Last Post SEQadmin2  
      Working...